Found: 23
Select item for more details and to access through your institution.
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE Program.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 4, p. 604, doi. 10.1159/000528788
- By:
- Publication type:
- Article
Cost-Utility Analysis of a Multidisciplinary Strategy to Manage Osteoarthritis of the Knee: Economic Evaluation of a Cluster Randomized Controlled Trial Study.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 6, p. 810, doi. 10.1002/acr.22232
- By:
- Publication type:
- Article
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231189122
- By:
- Publication type:
- Article
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231189122
- By:
- Publication type:
- Article
Long-term etanercept retention patterns and factors associated with treatment discontinuation: a retrospective cohort study using Canadian claims-level data.
- Published in:
- Clinical Rheumatology, 2018, v. 37, n. 9, p. 2351, doi. 10.1007/s10067-018-4141-z
- By:
- Publication type:
- Article
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 1, p. 226, doi. 10.1007/s12325-020-01501-z
- By:
- Publication type:
- Article
Comment on: "Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases".
- Published in:
- 2020
- By:
- Publication type:
- letter
Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1283, doi. 10.1093/ecco-jcc/jjae031
- By:
- Publication type:
- Article
Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1534, doi. 10.1111/apt.16848
- By:
- Publication type:
- Article
A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making.
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 119, doi. 10.2147/PPA.S220714
- By:
- Publication type:
- Article
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 2, p. 357, doi. 10.1007/s40744-022-00507-z
- By:
- Publication type:
- Article
Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 5, p. 1451, doi. 10.1007/s40744-022-00482-5
- By:
- Publication type:
- Article
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 2, p. 411, doi. 10.1007/s40744-021-00405-w
- By:
- Publication type:
- Article
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. 568, doi. 10.1093/rheumatology/kez324
- By:
- Publication type:
- Article
Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program.
- Published in:
- Patient, 2023, v. 16, n. 2, p. 95, doi. 10.1007/s40271-022-00603-w
- By:
- Publication type:
- Article
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2019, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12969-019-0358-x
- By:
- Publication type:
- Article
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 8, p. 1218, doi. 10.1002/art.42846
- By:
- Publication type:
- Article
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies.
- Published in:
- ACR Open Rheumatology, 2020, v. 2, n. 10, p. 543, doi. 10.1002/acr2.11166
- By:
- Publication type:
- Article
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 73, doi. 10.1002/acr2.1010
- By:
- Publication type:
- Article
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 2, p. 240, doi. 10.1002/acr.24966
- By:
- Publication type:
- Article
Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months.
- Published in:
- 2022
- By:
- Publication type:
- journal article